Compounds > metformin

metformin and gosogliptin

metformin has been researched along with gosogliptin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, H; Johnson, SL; Lewin, AJ; Nguyen, TT; Norwood, P; Rosenstock, J; Somayaji, V; Teeter, JG; Terra, SG1
Calle, RA; Dai, H; Lewin, AJ; Nguyen, TT; Schwartz, S; Somayaji, V; Teeter, JG; Terra, SG1

Trials

2 trial(s) available for metformin and gosogliptin

ArticleYear
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes.
    Diabetic medicine : a journal of the British Diabetic Association, 2011, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Epidemiologic Methods; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrimidines; Pyrrolidines; Treatment Outcome; Young Adult

2011
A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes*.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2011, Volume: 119, Issue:7

    Topics: Adolescent; Adult; Aged; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Protease Inhibitors; Pyrimidines; Pyrrolidines

2011